Ibrexafungerp | List of Frontiers open access articles

Review

Published on 11 Mar 2021

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

in Fungal Pathogenesis

Ahmed Gamal
Sherman Chu
Thomas S. McCormick
Katyna Borroto-Esoda
David Angulo
Mahmoud A. Ghannoum

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2021.642358

23,041 views
52 citations

Original Research

Published on 16 May 2022

In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

in Fungal Pathogenesis

Guillermo Quindós
Katherine Miranda-Cadena
Rosario San-Millán
Katyna Borroto-Esoda
Emilia Cantón
María José Linares-Sicilia
Axel Hamprecht
Isabel Montesinos
Anna Maria Tortorano
Anna Prigitano

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.906563

7,980 views
36 citations

Opinion

Published on 27 Jun 2024

Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics

in Pharmacology of Anti-Cancer Drugs

Tedi Rustandi
Abdul Mahmud Yumassik
Fitrah Shafran Ilahi
Riza Alfian
Erna Prihandiwati
Yugo Susanto
Yudi Hardi Susilo
Maria Ulfah
Faizatun Faizatun

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428755

3,042 views

Review

Published on 21 Aug 2024

A review of the fernane-type triterpenoids as anti-fungal drugs

in Experimental Pharmacology and Drug Discovery

Chun-Yue Liu
Lu Zhang
Si-Xuan Liu
Yong-Fu Lu
Chang Li
Yue-Hu Pei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447450

3,808 views
3 citations

Mini Review

Published on 21 Nov 2019

Fungal Cell Wall: Emerging Antifungals and Drug Resistance

in Fungi and Their Interactions

Soraia L. Lima
Arnaldo L. Colombo
João N. de Almeida Junior

Frontiers in Microbiology

doi 10.3389/fmicb.2019.02573

46,659 views
189 citations

Review

Accepted on 20 Apr 2026

Advances in Vulvovaginal Candidiasis Research: A Comprehensive Review from Epidemiology, Diagnosis, Treatment to Resistance Mechanisms

in Infectious Agents and Disease

Guo Liangsheng
Weipei Zhu

Frontiers in Microbiology

302 views

Articles

Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against Candida glabrata

In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

Repurposing therapy of ibrexafungerp vulvovaginal candidiasis drugs as cancer therapeutics

A review of the fernane-type triterpenoids as anti-fungal drugs

Fungal Cell Wall: Emerging Antifungals and Drug Resistance

Advances in Vulvovaginal Candidiasis Research: A Comprehensive Review from Epidemiology, Diagnosis, Treatment to Resistance Mechanisms